In the 6-hydroxydopamine-induced Parkinson’s disease rat model, administration of SB resulted in a substantial attenuation of motor deficits and also in an increase of striatal dopamine, BDNF, and global H3 histone acetylation levels [155]. The gene discussed is BDNF; the disease is Parkinson disease.